Junyu Long

3.8k total citations
82 papers, 2.0k citations indexed

About

Junyu Long is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Junyu Long has authored 82 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 36 papers in Surgery and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Junyu Long's work include Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers), Ferroptosis and cancer prognosis (17 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Junyu Long is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers), Ferroptosis and cancer prognosis (17 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Junyu Long collaborates with scholars based in China, United States and Germany. Junyu Long's co-authors include Haitao Zhao, Jianzhen Lin, Yi Bai, Xiaobo Yang, Dongxu Wang, Xinting Sang, Xu Yang, Anqiang Wang, Jianping Xiong and Weiyu Xu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Junyu Long

81 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junyu Long China	27	798	781	750	726	509	82	2.0k
Yuan‐Tzu Lan Taiwan	30	814 1.0×	1.5k 1.9×	544 0.7×	833 1.1×	680 1.3×	108	2.6k
Akira Tomokuni Japan	22	778 1.0×	570 0.7×	745 1.0×	339 0.5×	566 1.1×	93	1.8k
N Tanigawa Japan	25	1.2k 1.5×	868 1.1×	524 0.7×	638 0.9×	552 1.1×	48	2.3k
Angela Dalia Ricci Italy	31	679 0.9×	1.7k 2.1×	538 0.7×	1.1k 1.5×	1.1k 2.3×	97	3.0k
Junichiro Hiro Japan	27	556 0.7×	980 1.3×	478 0.6×	360 0.5×	474 0.9×	114	1.9k
Changping Wu China	25	673 0.8×	1.3k 1.6×	599 0.8×	508 0.7×	309 0.6×	58	2.4k
Hisashi Nagahara Japan	31	622 0.8×	1.7k 2.2×	686 0.9×	689 0.9×	779 1.5×	128	2.9k
Hakan Alakus Germany	29	743 0.9×	763 1.0×	518 0.7×	925 1.3×	900 1.8×	113	2.3k
Yanong Wang China	23	992 1.2×	339 0.4×	800 1.1×	478 0.7×	489 1.0×	54	1.8k

Countries citing papers authored by Junyu Long

Since Specialization

Citations

This map shows the geographic impact of Junyu Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyu Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyu Long more than expected).

Fields of papers citing papers by Junyu Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyu Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyu Long. The network helps show where Junyu Long may publish in the future.

Co-authorship network of co-authors of Junyu Long

This figure shows the co-authorship network connecting the top 25 collaborators of Junyu Long. A scholar is included among the top collaborators of Junyu Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyu Long. Junyu Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Chengpei, Shanshan Wang, Yunchao Wang, et al.. (2024). Efficacy and safety of lenvatinib combined with anti-PD-1 antibodies plus GEMOX chemotherapy as non-first-line systemic therapy in advanced gallbladder cancer. Cancer Immunology Immunotherapy. 73(12). 240–240. 1 indexed citations

Xun, Ziyu, Junyu Long, Xu Yang, et al.. (2024). Immunosuppression and phenotypic plasticity in an atlas of human hepatocholangiocarcinoma. HepatoBiliary Surgery and Nutrition. 13(4). 586–603. 2 indexed citations

Chen, Peipei, Junyu Long, Fucun Xie, et al.. (2024). Identification and validation of the association of Janus kinase 2 mutations with the response to immune checkpoint inhibitor therapy. Inflammation Research. 73(2). 263–276.

Chen, Peipei, Junyu Long, Ying Xiao, et al.. (2024). Transcriptome and open chromatin analysis reveals the process of myocardial cell development and key pathogenic target proteins in Long QT syndrome type 7. Journal of Translational Medicine. 22(1). 307–307. 1 indexed citations

Chen, Guangyu, Yueze Liu, Dan Su, et al.. (2023). Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer. Cellular Oncology. 46(6). 1691–1708. 1 indexed citations

Wang, Yanyu, Xu Yang, Junyu Long, et al.. (2023). Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma. World Journal of Gastroenterology. 29(10). 1614–1626. 21 indexed citations

Long, Junyu, et al.. (2022). eRNAs Identify Immune Microenvironment Patterns and Provide a Novel Prognostic Tool in Acute Myeloid Leukemia. Frontiers in Molecular Biosciences. 9. 877117–877117. 2 indexed citations

Zheng, Mingjun, Junyu Long, Anca Chelariu-Raicu, et al.. (2021). Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer. Cancers. 13(13). 3343–3343. 19 indexed citations

Lin, Jianzhen, Xinxin Peng, Junyu Long, et al.. (2021). Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer. Nature Communications. 12(1). 4753–4753. 22 indexed citations

10.

Lin, Jianzhen, Songhui Zhao, Dongxu Wang, et al.. (2021). Targeted Next-Generation Sequencing Combined With Circulating-Free DNA Deciphers Spatial Heterogeneity of Resected Multifocal Hepatocellular Carcinoma. Frontiers in Immunology. 12. 673248–673248. 6 indexed citations

11.

Bian, Jin‐Song, Junyu Long, Xu Yang, et al.. (2021). Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma. Annals of Translational Medicine. 9(9). 765–765. 7 indexed citations

12.

Yang, Xiaobo, Haifeng Xu, Yang Xu, et al.. (2021). Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy. HepatoBiliary Surgery and Nutrition. 10(4). 434–442. 37 indexed citations

13.

Sundar, Sudha, Sunil Kumar, Junyu Long, et al.. (2020). PATIENT REPORTED OUTCOMES (PRO) AFTER SURGERY IN ADVANCED OVARIAN CANCER - INITIAL RESULTS FROM THE INTERNATIONAL, PROSPECTIVE, MULTICENTER SOCQER 2 STUDY. Queen Mary Research Online (Queen Mary University of London). 1 indexed citations

14.

Zhang, Xinmu, Xin Nie, Junyu Long, et al.. (2020). Expression of p42.3 in non-small cell lung cancer. Annals of Translational Medicine. 8(13). 819–819. 4 indexed citations

15.

Lin, Jianzhen, Junping Shi, Honglin Guo, et al.. (2019). Alterations in DNA Damage Repair Genes in Primary Liver Cancer. Clinical Cancer Research. 25(15). 4701–4711. 80 indexed citations

16.

Long, Junyu, Peipei Chen, Jianzhen Lin, et al.. (2019). DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma. Theranostics. 9(24). 7251–7267. 99 indexed citations

17.

Xu, Weiyu, Jianping Xiong, Jianzhen Lin, et al.. (2018). Prognostic role of neutrophil-to-lymphocyte ratio in unresectable hepatocellular cancer patients treated with trans-arterial chemoembolization. Translational Cancer Research. 7(4). 1122–1134. 2 indexed citations

18.

Xu, Weiyu, Wen-Qin Wang, Min Yang, et al.. (2018). Prognostic significance of the platelet-to-lymphocyte ratio in ovarian cancer: a meta-analysis. Translational Cancer Research. 7(3). 552–560. 3 indexed citations

19.

Long, Junyu, Jianzhen Lin, Anqiang Wang, et al.. (2017). PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy. Journal of Hematology & Oncology. 10(1). 146–146. 84 indexed citations

20.

Xie, Yuan, Jianzhen Lin, Weiyu Xu, et al.. (2017). Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer. World Journal of Gastroenterology. 23(31). 5787–5787. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact